Showing results (41-50 of 257) with videos related to
Sort By:
Pageof 26
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 5, 2016
Pegfilgrastim in primary prophylaxis of febrile neutropenia following frontline bendamustine plus rituximab treatment in patients with indolent non-Hodgkin lymphoma: a single center, real-life experienceClaudio Cerchione, Amalia De Renzo, Maria Di Perna, et al.Leukemia Research|January 1, 2014
Identifying and addressing unmet clinical needs in Ph-neg classical myeloproliferative neoplasms: a consensus-based SIE, SIES, GITMO position paperGiovanni Barosi, Alessandro M Vannucchi, Valerio De Stefano, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 17, 2012
Metabolic tumor volume assessed by 18F-FDG PET/CT for the prediction of outcome in patients with multiple myelomaRosa Fonti, Michele Larobina, Silvana Del Vecchio, et al.Radiology|April 9, 2014
Advanced-stage Hodgkin lymphoma: US/chest radiography for detection of relapse in patients in first complete remission--a randomized trial of routine surveillance imaging proceduresMarco Picardi, Novella Pugliese, Michele Cirillo, et al.Acta Haematologica|May 26, 2025
Ultrasonography-Guided Core-Needle Biopsy for Newly Diagnosed Large B-Cell Lymphomas: Analysis on Diagnostic Efficacy and Safety in an Italian Retrospective StudyMarco Picardi, Claudia Giordano, Annamaria Vincenzi, et al.Clinical Nuclear Medicine|January 22, 2015
18F-FDG PET/CT, 99mTc-MIBI, and MRI in the prediction of outcome of patients with multiple myeloma: a comparative studyRosa Fonti, Leonardo Pace, Claudio Cerchione, et al.Haematologica|October 13, 2004
The achievement of molecular complete remission during treatment with imatinib mesylate correlates with relapse-free survival in bcr/abl-positive acute lymphoid leukemia patientsPier Paolo Piccaluga, Michele Malagola, Marilina Amabile, et al.Cancer Genetics and Cytogenetics|June 2, 2006
Molecular cytogenetic characterization of deletions on der(9) in chronic myelocytic leukemiaAntonella Zagaria, Luisa Anelli, Francesco Albano, et al.Future Oncology (London, England)|January 18, 2023
ENABLE: treatment combination including decitabine and venetoclax in acute myeloid leukemia secondary to myeloproliferative neoplasmsFrancesco Mannelli, Paola Guglielmelli, Paola Fazi, et al.Blood|September 24, 2010
Preferential nuclear accumulation of JAK2V617F in CD34+ but not in granulocytic, megakaryocytic, or erythroid cells of patients with Philadelphia-negative myeloproliferative neoplasiaCiro R Rinaldi, Paola Rinaldi, Adele Alagia, et al.Pageof 26